Guide to Amylase

WRITTEN BY
Updated: 05/22/2025|12 min read

Summary

Amylase is an enzyme that helps digest carbohydrates. It's mainly produced in the pancreas and salivary glands.

Why It Matters

Amylase breaks down carbohydrates into simple sugars. Under normal circumstances, amylase remains primarily in the digestive tract, with only small amounts circulating in the bloodstream. However, when certain organs, particularly the pancreas or salivary glands, become damaged or inflamed, increased amounts of amylase may be produced and leak into the bloodstream, causing elevated serum levels.

The most common cause of elevated amylase levels is acute pancreatitis, or inflammation of the pancreas. It can be caused by gallstones, alcohol abuse, certain medications, or high cholesterol. Inflammation or obstruction of the salivary glands can also lead to elevated amylase levels, though typically to a lesser extent than pancreatic issues.

Low amylase levels can also be clinically significant, typically indicating that your body isn't producing enough of this enzyme. This could stem from a problem with the pancreas or salivary glands, such as chronic pancreatitis or fatty pancreas disease where enzyme-producing cells have been damaged or lost. Low levels may also result from insufficient caloric or nutrient intake, chronic stress, or certain medications that affect enzyme production. Interestingly, low amylase is increasingly being recognized in metabolic conditions like obesity, prediabetes/diabetes, metabolic syndrome, and non-alcoholic fatty liver disease, potentially reflecting a complex relationship between pancreatic function and metabolic health.

Amylase levels often rise rapidly within hours of injury or inflammation and return to normal within a few days as the condition improves. This pattern makes amylase useful for diagnosing acute conditions and monitoring their progression. However, other markers may be more helpful in diagnosing chronic conditions.

Associated Symptoms

Amylase levels themselves are laboratory findings rather than medical conditions. However, abnormal levels may be associated with various health issues, each with its own symptoms.

Common symptoms that may indicate conditions associated with high amylase:

  • Upper abdominal pain: Severe pain that often radiates to the back, result from pancreatic inflammation and tissue damage
  • Nausea and vomiting: Digestive disturbances, may be due to inflammation affecting surrounding organs and nerves
  • Abdominal tenderness: Sensitivity to touch in the upper abdomen, may result from swelling and inflammation of the pancreas
  • Fever: Elevated body temperature, may be in response to the inflammatory process
  • Tachycardia: Rapid heart rate, may be due to pain, dehydration, and systemic inflammatory response
  • Jaundice: Yellowing of skin and eyes in some cases, can indicate bile duct obstruction or liver involvement

Common symptoms that may indicate conditions associated with low amylase:

  • Digestive discomfort: Bloating, gas, or discomfort after consuming starchy foods, may be due to inadequate carbohydrate digestion
  • Diarrhea: Loose stools containing undigested food particles, can result from impaired carbohydrate breakdown
  • Weight loss: Unintended decrease in body weight, may result from malabsorption of nutrients
  • Steatorrhea: Foul-smelling, fatty stools that may float, can indicate pancreatic insufficiency affecting multiple digestive enzymes

It's important to understand that symptoms associated with amylase abnormalities typically reflect the underlying condition rather than the enzyme level itself. For example, high amylase symptoms generally represent pancreatitis or salivary gland disorders, while low amylase symptoms often indicate chronic pancreatic insufficiency. The pattern, severity, and progression of symptoms, combined with laboratory findings, help your doctor determine the underlying cause.

Clinical Ranges

  • Lab Reference Range: 21-101 U/L

Lifestyle Factors That Can Impact It

Activities that may affect amylase include:

  • Alcohol consumption: Regular and excessive alcohol intake can damage the pancreas, potentially leading to both acute and chronic pancreatitis.
  • High-fat diet: High-fat diets may stress the pancreas in some people, potentially affecting amylase levels.
  • Hydration: Dehydration may concentrate amylase levels in the blood and potentially exacerbate pancreatic conditions.
  • Smoking: Tobacco use is a risk factor for pancreatic disease and may indirectly affect amylase levels by damaging pancreatic tissue over time.

Other Factors That Can Impact It

Medical Conditions

  • Acute pancreatitis: An inflammatory condition of the pancreas that leads to the release of digestive enzymes that damage pancreatic tissue, can cause severe pain and elevated amylase levels.
  • Chronic pancreatitis: Long-term inflammation and scarring of the pancreas that can cause normal or low amylase levels as the damaged pancreas loses its ability to produce enzymes.
  • Pancreatic cancer: Tumors in the pancreatic glands or ducts can affect the glands' ability to produce and release digestive enzymes, including amylase.
  • Salivary gland disorders: Inflammation, infection, or obstruction of the salivary glands (mumps, sialadenitis, salivary stones) can cause elevated salivary amylase levels in the blood.
  • Renal insufficiency: When kidney function is impaired, the clearance of amylase from the bloodstream is impaired, potentially leading to elevated levels.
  • Obesity: Often associated with low amylase levels, potentially reflecting altered pancreatic function.
  • Diabetes and prediabetes: Frequently show reduced amylase production, suggesting a link between glucose metabolism and pancreatic enzyme function.
  • Metabolic syndrome: Associated with lower amylase levels, possibly indicating pancreatic dysfunction.
  • Non-alcoholic fatty liver disease: May present with decreased amylase, reflecting the metabolic relationship between liver and pancreatic health.
  • Fatty pancreas disease: Accumulation of fat in the pancreas can impair enzyme production, including amylase.
  • Intestinal disease: Conditions such as intestinal obstruction or inflammatory bowel disease (IBD) can affect amylase levels.
  • Ectopic pregnancy: Can cause abnormal amylase levels due to inflammation.
  • Liver failure: Advanced liver disease can disrupt enzyme metabolism, affecting amylase levels.

Medications and Supplements

  • Medications that affect amylase levels: aspirin, opiates, some antibiotics, oral contraceptives, and thiazide diuretics
  • In very rare instances, cholesterol-lowering drugs like statins may cause acute pancreatitis.
  • Some chemotherapy agents may damage pancreatic tissue.
  • Corticosteroids can cause an increase in amylase production and secretion

Individual Factors

  • Pregnancy: Normal changes during pregnancy may affect amylase levels
  • Body mass index: Obesity is a risk factor for gallstone formation, which can lead to pancreatitis and elevated amylase

Testing Accuracy and Stability

Amylase testing is generally reliable but may be impacted by certain procedures or conditions.

Factors That Can Affect the Accuracy of Your Test

  • Recent endoscopic procedures or surgery involving the pancreatic area
  • Especially with acute pancreatitis, the timing of blood collection relative to the onset of symptoms is crucial when interpreting amylase and lipase levels. If testing is delayed, the sensitivity of amylase may be reduced due to its relatively short half-life of 12 hours.
  • Kidney disease
  • Macroamylasemia (a benign condition where amylase binds to proteins in the blood)
  • Hemolysis (breakdown of red blood cells) or lipemia (elevated fat content) in the blood sample

How It Relates to Other Markers

Your doctor may review other tests to provide insights about health status, including:

  • Lipase: A pancreatic enzyme that tends to rise more quickly and remain elevated longer than amylase after pancreatic injury.
  • C-reactive protein (CRP): An inflammatory marker that helps assess the severity of inflammation in pancreatitis.
  • Complete blood count (CBC): Evaluates for signs of infection or inflammation that might accompany pancreatic disorders.
  • Liver function tests: Help determine if gallstones may be the cause of elevated amylase. Elevated liver enzymes with high amylase may suggest a gallstone-related cause of pancreatitis

How Results Could Relate to Other Marker Values

  • High amylase + high lipase: May suggest pancreatic conditions.
  • High amylase + normal lipase: May suggest macroamylasaemia.
  • High amylase + high CRP: Could suggest acute inflammation.
  • High amylase + high white blood cell count: Could indicate an inflammation or infection.
  • High amylase + high liver enzymes: May suggest a gallstone-related cause of pancreatitis or liver damage

Follow-up Considerations

If amylase is high, your provider may work with you on a plan to address any levels that were out of range. Here are some recommendations they might make. You should always speak to your doctor if you have medical questions or before making medical decisions.

When Re-Testing May be Appropriate

  • 24-48 hours after initial elevation to monitor trend
  • After symptoms go away to confirm return to normal levels
  • Periodically in chronic pancreatic conditions to assess disease activity
  • Following changes in treatment for pancreatic disorders

Additional Testing Your Doctor May Consider

  • Abdominal ultrasound or CT scan to visualize the pancreas and biliary system
  • MRCP (Magnetic Resonance Cholangiopancreatography) for detailed imaging of pancreatic and biliary duct systems
  • Endoscopic ultrasound for direct visualization of pancreatic tissue and potential biopsy
  • Genetic testing if hereditary pancreatitis is suspected

When Additional Care May be Warranted

  • Persistent severe abdominal pain despite treatment
  • Signs of dehydration or inability to tolerate oral fluids
  • Fever above 101°F
  • Jaundice developing after diagnosis of pancreatitis
  • Persistent vomiting or worsening abdominal distention
  • No improvement in symptoms after 48-72 hours of treatment

Bibliography

References

1. Forsmark, Chris E., Santhi Swaroop Vege, and C. Mel Wilcox. "Acute Pancreatitis." New England Journal of Medicine, vol. 375, no. 20, 2016, pp. 1972--1981. DOI: 10.1056/NEJMra1505202.

2. Tenner, Scott, et al. "American College of Gastroenterology Guideline: Management of Acute Pancreatitis." American Journal of Gastroenterology, vol. 108, no. 9, 2013, pp. 1400--1415. DOI: 10.1038/ajg.2013.218.

3. Lippi, Giuseppe, Massimo Valentino, and Giovanni Cervellin. "Laboratory Diagnosis of Acute Pancreatitis: In Search of the Holy Grail." Critical Reviews in Clinical Laboratory Sciences, vol. 49, no. 1, 2012, pp. 18--31. DOI: 10.23736/S2724-5985.20.02699-9.

4. Yadav, Dhiraj, and Albert B. Lowenfels. "The Epidemiology of Pancreatitis and Pancreatic Cancer." Gastroenterology, vol. 144, no. 6, 2013, pp. 1252--1261. DOI: 10.1053/j.gastro.2013.01.068.

5. Ismail, Ozma Z., and Vikas Bhayana. "Lipase or Amylase for the Diagnosis of Acute Pancreatitis?" Clinical Biochemistry, vol. 50, no. 18, 2017, pp. 1275--1280. DOI: DOI: 10.1016/j.clinbiochem.2017.07.003.

6. Lankisch, Paul G., Minoti V. Apte, and Peter A. Banks. "Acute Pancreatitis." The Lancet, vol.6, no. 9988, 2015, pp. 85--96. 38. DOI: 10.1016/S0140-6736(14)60649-8.

7. Akinfemiwa, Oluwaseun, et al. "Amylase." StatPearls, updated 12 Nov. 2023, StatPearls Publishing, 2025.

8. Ahmad, R., et al. "C-Reactive Protein as a Predictor of Complicated Acute Pancreatitis: Reality or a Myth?" Cureus, vol. 13, no. 11, 2021, article e19265. DOI: 10.7759/cureus.19265.\

9. Lam, Raymond, and Thiruvengadam Muniraj. "Hyperamylasemia." StatPearls, updated 11 Dec. 2022, StatPearls Publishing, 2025.

10. MacGregor, Ian L., et al. "A Cause of Hyperamylasemia Associated with Chronic Liver Disease." Gastroenterology, vol. 72, no. 3, 1977, pp. 519--523.

11. Benjamin, Omayma, and Stephanie L. Lappin. "Chronic Pancreatitis." StatPearls, updated 21 Jun. 2022, StatPearls Publishing, 2025.

12. Tedesco, F. J., et al. "Serum Amylase Determinations and Amylase to Creatinine Clearance Ratios in Patients with Chronic Renal Insufficiency." Gastroenterology, vol. 71, no. 4,

13. Amiri, B., et al. "Inhibitory Effects of Selected Antibiotics on the Activities of α-Amylase and α-Glucosidase: In-vitro, In-vivo and Theoretical Studies." European Journal of Pharmaceutical Sciences, vol. 138, 2019, article 105040. DOI: 10.1016/j.ejps.2019.105040.

14. Etienne, Danie, and Youssef Reda. "Statins and Their Role in Acute Pancreatitis: Case Report and Literature Review." World Journal of Gastrointestinal Pharmacology and Therapeutics, vol. 5, no. 3, 2014, pp. 191--195. DOI: 10.4292/wjgpt.v5.i3.191.

15. Ngo, Duy, et al. "Cancer Therapy Related Complications in the Liver, Pancreas, and Biliary System: An Imaging Perspective." Insights into Imaging, vol. 6, no. 6, 2015, pp. 665--677. https://doi.org/10.1007/s13244-015-0436-7.

16. Yang, Qing-Jie, et al. "Acute Pancreatitis Induced by Combination Chemotherapy Used for the Treatment of Acute Myeloid Leukemia: A Case Report." Medicine (Baltimore), vol. 99, no. 35, 2020, article e21848. DOI: 10.1097/MD.0000000000021848.

17. Logsdon, Craig D., et al. "Glucocorticoids Increase Amylase mRNA Levels, Secretory Organelles, and Secretion in Pancreatic Acinar AR42J Cells." Journal of Cell Biology, vol. 100, no. 4, 1985, pp. 1200--1208. DOI: 10.1083/jcb.100.4.1200.

18. Logsdon, Craig D., et al. "Mechanism of Glucocorticoid-Induced Increase in Pancreatic Amylase Gene Transcription." Journal of Biological Chemistry, vol. 262, no. 32, 1987, pp. 15765--15769. DOI: 10.1016/S0021-9258(18)47795-2.

19. Kaiser, Richard, et al. "Serum Amylase Changes During Pregnancy." American Journal of Obstetrics and Gynecology, vol. 122, no. 3, 1975, pp. 283--286. Link

20. Khatua, Bappaditya, et al. "Obesity and Pancreatitis." Current Opinion in Gastroenterology, vol. 33, no. 5, 2017, pp. 374--382. DOI: 10.1097/MOG.0000000000000386.

21. Testoni, Pier Alberto, et al. "Serum Amylase Measured Four Hours After Endoscopic Sphincterotomy is a Reliable Predictor of Postprocedure Pancreatitis." American Journal of Gastroenterology, vol. 94, no. 5, 1999, pp. 1235--1241. DOI: 10.1111/j.1572-0241.1999.01072.x.

22. Fukada, Masashi, et al. "Drain Fluid and Serum Amylase Concentration Ratio is the Most Reliable Indicator for Predicting Postoperative Pancreatic Fistula after Distal Pancreatectomy." BMC Surgery, vol. 23, 2023, article 87. DOI: 10.1186/s12893-023-01980-1.

23. Kurt, Özge, et al. "Severe Serum Amylase Elevation, with Only Chronic Kidney Disease." Renal Failure, vol. 37, no. 5, 2015, pp. 915--916. DOI: 10.3109/0886022X.2015.1022852.

24. Al-Johani, Waleed M. "Macroamylasemia as a Rare Cause of Hyperamylasemia: A Case Report." Korean Journal of Family Medicine, vol. 44, no. 6, 2023, pp. 347--349. DOI: 10.4082/kjfm.23.0195.

25. Krasowski, Matthew D. "Educational Case: Hemolysis and Lipemia Interference with Laboratory Testing." Academic Pathology, vol. 6, 2019, article 2374289519888754. DOI: 10.1177/2374289519888754.

26. Akhtar, Anam, et al. "Measuring Both Serum Amylase and Lipase for Acute Pancreatitis Lowers Quality and Raises Cost." Cleveland Clinic Journal of Medicine, vol. 84, no. 9, 2017, pp. 670--672. DOI: 10.3949/ccjm.84a.16103.

27. Ahmad, R., et al. "C-Reactive Protein as a Predictor of Complicated Acute Pancreatitis: Reality or a Myth?" Cureus, vol. 13, no. 11, 2021, article e19265. DOI: 10.7759/cureus.19265. (Duplicate of entry #8)Guide to amylase

Sign up for the Levels Newsletter